PMV Pharmaceuticals Statistics
Total Valuation
PMVP has a market cap or net worth of $84.49 million. The enterprise value is -$115.95 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, before market open.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
PMVP has 51.52 million shares outstanding. The number of shares has increased by 11.19% in one year.
| Shares Outstanding | 51.52M |
| Shares Change (YoY) | +11.19% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 2.15% |
| Owned by Institutions (%) | 61.62% |
| Float | 41.23M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.39 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.22, with a Debt / Equity ratio of 0.06.
| Current Ratio | 19.22 |
| Quick Ratio | 18.70 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -22.62% and return on invested capital (ROIC) is -20.82%.
| Return on Equity (ROE) | -22.62% |
| Return on Assets (ROA) | -19.88% |
| Return on Capital (ROIC) | -20.82% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$775,857 |
| Employee Count | 63 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -16.18M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -14.14% in the last 52 weeks. The beta is 1.48, so PMVP's price volatility has been higher than the market average.
| Beta (5Y) | 1.48 |
| 52-Week Price Change | -14.14% |
| 50-Day Moving Average | 1.55 |
| 200-Day Moving Average | 1.67 |
| Relative Strength Index (RSI) | 57.20 |
| Average Volume (20 Days) | 190,959 |
Short Selling Information
The latest short interest is 975,907, so 1.89% of the outstanding shares have been sold short.
| Short Interest | 975,907 |
| Short Previous Month | 1.04M |
| Short % of Shares Out | 1.89% |
| Short % of Float | 2.37% |
| Short Ratio (days to cover) | 4.90 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -76.29M |
| Pretax Income | -65.05M |
| Net Income | -48.88M |
| EBITDA | -74.84M |
| EBIT | -76.29M |
| Earnings Per Share (EPS) | -$0.96 |
Full Income StatementBalance Sheet
The company has $212.92 million in cash and $12.99 million in debt, giving a net cash position of $199.93 million or $3.88 per share.
| Cash & Cash Equivalents | 212.92M |
| Total Debt | 12.99M |
| Net Cash | 199.93M |
| Net Cash Per Share | $3.88 |
| Equity (Book Value) | 214.32M |
| Book Value Per Share | 4.16 |
| Working Capital | 207.40M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$45.53 million and capital expenditures -$839,000, giving a free cash flow of -$46.37 million.
| Operating Cash Flow | -45.53M |
| Capital Expenditures | -839,000 |
| Free Cash Flow | -46.37M |
| FCF Per Share | -$0.90 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |